Save Natural Pain Treatment!

The Drug Enforcement Agency (DEA) is moving against cannabidiol (CBD), a supplement used to control pain and inflammation. The circumstances are extremely suspicious.

Late last year, the DEA published a final rule that classifies marijuana and hemp extracts, including CBD, as Schedule 1 controlled substances—a category that includes heroin, LSD, mescaline, and MDMA. Note that none of the CBD extracts contains significant amounts of the psychoactive chemical in marijuana—only the non-psychoactive painkilling chemicals.

This is not a merely irrational move by the DEA—it’s a deeply suspicious one. The US government holds a patent on CBD that covers the use of CBD to protect the brain from degeneration and the treatment of diseases like Alzheimer’s and Parkinson’s.

Sound familiar? The US Food and Drug Administration (FDA) has been obsessed with natural remedies that can treat Alzheimer’s. So far, the agency has attacked supplements such as picamilon, vinpocetine, and pyridoxamine, essentially clearing the field for expensive Big Pharma-owned Alzheimer’s drugs that they know don’t work. The government seems to be employing the same playbook against CBD.

Send a message to the DEA, with a copy to Congress, telling them to reverse this flawed decision.


  • Your Senators
  • Your Representative
  • Drug Enforcement Agency


*Required fields


Please maintain access to CBD

Dear [Decision Maker],

[Your Name]
[Your Address]
[City, State ZIP]
[Your Email]